NO20043383L - Faste krystallinske stoffer av karvedilol og fremgangsmater for fremstilling av disse - Google Patents

Faste krystallinske stoffer av karvedilol og fremgangsmater for fremstilling av disse

Info

Publication number
NO20043383L
NO20043383L NO20043383A NO20043383A NO20043383L NO 20043383 L NO20043383 L NO 20043383L NO 20043383 A NO20043383 A NO 20043383A NO 20043383 A NO20043383 A NO 20043383A NO 20043383 L NO20043383 L NO 20043383L
Authority
NO
Norway
Prior art keywords
carvedilol
processes
preparation
solid crystalline
crystalline substances
Prior art date
Application number
NO20043383A
Other languages
English (en)
Norwegian (no)
Inventor
Shlomit Wizel
Ilan Kor
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23371828&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20043383(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of NO20043383L publication Critical patent/NO20043383L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
NO20043383A 2002-01-15 2004-08-13 Faste krystallinske stoffer av karvedilol og fremgangsmater for fremstilling av disse NO20043383L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34931002P 2002-01-15 2002-01-15
PCT/US2003/001137 WO2003059807A2 (en) 2002-01-15 2003-01-15 Crystalline solids of carvedilol and processes for their preparation

Publications (1)

Publication Number Publication Date
NO20043383L true NO20043383L (no) 2004-08-13

Family

ID=23371828

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20043383A NO20043383L (no) 2002-01-15 2004-08-13 Faste krystallinske stoffer av karvedilol og fremgangsmater for fremstilling av disse

Country Status (14)

Country Link
US (3) US6710184B2 (is)
EP (1) EP1474133A4 (is)
JP (1) JP2005515226A (is)
KR (1) KR20040077872A (is)
CN (1) CN1298322C (is)
AU (1) AU2003205146A1 (is)
CA (1) CA2472377A1 (is)
HR (1) HRP20040673A2 (is)
IS (1) IS7351A (is)
MX (1) MXPA04006909A (is)
NO (1) NO20043383L (is)
PL (1) PL371409A1 (is)
WO (1) WO2003059807A2 (is)
ZA (1) ZA200405443B (is)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6389455B1 (en) * 1998-09-22 2002-05-14 Richard C. Fuisz Method and apparatus for bouncing electronic messages
US20010036959A1 (en) * 2000-04-03 2001-11-01 Gabel Rolf Dieter Carvedilol-hydrophilic solutions
US6699997B2 (en) 2000-06-28 2004-03-02 Teva Pharmaceutical Industries Ltd. Carvedilol
US7122376B2 (en) * 2001-11-01 2006-10-17 Facet Analytical Services And Technology, Llc Calibration standards, methods, and kits for water determination
US7049146B2 (en) 2000-11-14 2006-05-23 Facet Analytical Services And Technology, Llc Calibration standards, methods, and kits for water determination
US8101209B2 (en) 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
PL371409A1 (en) 2002-01-15 2005-06-13 Teva Pharmaceutical Industries Ltd. Crystalline solids of carvedilol and processes for their preparation
WO2003092622A2 (en) * 2002-04-30 2003-11-13 Sb Pharmco Puerto Rico Inc. Carvedilol monocitrate monohydrate
CA2492084A1 (en) * 2002-06-27 2004-01-08 Sb Pharmco Puerto Rico Inc. Carvedilol hydobromide
AU2003248746B2 (en) * 2002-06-27 2009-01-08 Smithkline Beecham (Cork) Limited Carvedilol phosphate salts and/or solvates thereof, corresponding compositions, and/or methods of treatment
US20040152756A1 (en) * 2002-07-15 2004-08-05 Wei Chen Carvedilol polymorph
WO2004094378A1 (en) * 2003-04-21 2004-11-04 Matrix Laboratories Ltd Process for the preparation of carvedilol form-ii
US20050042182A1 (en) * 2003-08-13 2005-02-24 Moshe Arkin Topical compositions of urea
US20050037040A1 (en) * 2003-08-13 2005-02-17 Moshe Arkin Topical compositions of urea and ammonium lactate
US20050036953A1 (en) * 2003-08-13 2005-02-17 Moshe Arkin Topical compositions of ammonium lactate
US20050042268A1 (en) * 2003-07-16 2005-02-24 Chaim Aschkenasy Pharmaceutical composition and method for transdermal drug delivery
SI21616A (sl) * 2003-09-02 2005-04-30 Krka, Tovarna Zdravil, D.D., Novo Mesto Nove kristalne oblike karvedilola
US20050069499A1 (en) * 2003-09-25 2005-03-31 Moshe Arkin Foamable compositions, processes of preparing same and uses thereof
JP2007512350A (ja) * 2003-11-25 2007-05-17 エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド カルベジロール組成物の治療および送達方法
US7750036B2 (en) * 2003-11-25 2010-07-06 Sb Pharmco Puerto Rico Inc. Carvedilol salts, corresponding compositions, methods of delivery and/or treatment
US20060057075A1 (en) * 2004-08-02 2006-03-16 Moshe Arkin Pharmaceutical and cosmeceutical wash-off mousse shampoo compositions, processes for preparing the same and uses thereof
WO2006135757A1 (en) * 2005-06-09 2006-12-21 Teva Pharmaceutical Industries Ltd. Crystalline forms of carvedilol and processes for their preparation
WO2007043938A1 (en) * 2005-10-07 2007-04-19 Astrazeneca Ab NOVEL CRYSTALLINE FORM OF 3,5-DIBROMO-N- [ (2S) -2- (-4- FLUOROPHENYL) -4- (3-MORPHOLIN-4-YLAZTIDIN-l-YL) BUTYL] -N METHYLBENZAMIDE, MODIFICATION B
WO2007077111A1 (en) * 2005-12-30 2007-07-12 F. Hoffmann-La Roche Ag Compounds and methods for carbazole synthesis
EP1991527A2 (en) 2006-06-28 2008-11-19 Teva Pharmaceutical Industries Ltd Polymorphous forms of carvedilol phosphate
RU2366653C2 (ru) * 2006-07-03 2009-09-10 Ооо "Нанокриохимия" Способ получения рентгеноаморфной модификации карведилола
GB2442238B (en) * 2006-09-29 2008-10-01 Rolls Royce Plc Sheet metal blank
US20080249317A1 (en) * 2007-04-04 2008-10-09 Apotex Inc. Novel amorphous form of carvedilol phosphate and processes for the preparation thereof
EP2257177A4 (en) * 2007-11-14 2012-07-11 Manuel Gidekel NEW EXTRACTS OF DESCHAMPSIA ANTARCTICA DESV. WITH ANTINEOPLASTIC EFFECT
WO2015031914A1 (en) * 2013-08-30 2015-03-05 Uti Limited Partnership Store overload-induced calcium release inhibitors and methods for producing and using the same
KR102495018B1 (ko) 2013-11-15 2023-02-06 아케비아 테라퓨틱스 인코포레이티드 ｛[5-(3-클로로페닐)-3-하이드록시피리딘-2-카보닐]아미노｝아세트산의 고체형, 이의 조성물 및 용도

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2815926A1 (de) 1978-04-13 1979-10-18 Boehringer Mannheim Gmbh Neue carbazolyl-(4)-oxy-propanolamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3319027A1 (de) 1983-05-26 1984-11-29 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur herstellung von optisch aktiven carbazol-derivaten, neue r- und s-carbazol-derivate, sowie arzneimittel, die diese verbindungen enthalten
FR2725623A1 (fr) 1994-10-18 1996-04-19 Flamel Tech Sa Microcapsules medicamenteuses et/ou nutritionnelles pour administration per os
US5760069A (en) 1995-02-08 1998-06-02 Boehringer Mannheim Pharmaceuticals Corporation-Smithkline Beecham Corporation Limited Partnership #1 Method of treatment for decreasing mortality resulting from congestive heart failure
EP0893440A1 (en) * 1997-07-22 1999-01-27 Roche Diagnostics GmbH Thermodynamically stable modification of 1-(4-carbazolyloxy)-3-[2-(2-methoxyphenoxy)ethylamino]-2-propanole, process for its preparation and pharmaceutical compositions containing it
US6730326B2 (en) 1997-07-22 2004-05-04 Roche Diagnostics Gmbh Thermodynamically stable modification of 1-(4-carbazolyl-oxy-3[2-(2-methoxyphenoxy)-ethylamino]-2-propanol process for its preparation and pharmaceutical compositions containing it
HU227441B1 (en) * 1997-11-24 2011-06-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Process for producing carvedilol, enantiomers and salts thereof
DE19954569A1 (de) 1999-11-12 2001-05-17 Schwabe Willmar Gmbh & Co Pharmakologisch aktive Tetrahydrothiopyran-4-ol-Derivate, Verfahren zu ihrer Herstellung und Verwendung
US6699997B2 (en) * 2000-06-28 2004-03-02 Teva Pharmaceutical Industries Ltd. Carvedilol
MXPA03006606A (es) 2001-01-25 2003-09-22 Hoffmann La Roche Proceso para preparacion de analogos de indeno heterociclico.
DE60212130D1 (en) * 2001-07-13 2006-07-20 Smithkline Beecham Corp Carvedilolpolymorph
ES2291503T3 (es) 2001-09-28 2008-03-01 F. Hoffmann-La Roche Ag Formas pseudopolimorficas de carvedilol.
PL371409A1 (en) 2002-01-15 2005-06-13 Teva Pharmaceutical Industries Ltd. Crystalline solids of carvedilol and processes for their preparation
AU2003248746B2 (en) 2002-06-27 2009-01-08 Smithkline Beecham (Cork) Limited Carvedilol phosphate salts and/or solvates thereof, corresponding compositions, and/or methods of treatment
US20040152756A1 (en) * 2002-07-15 2004-08-05 Wei Chen Carvedilol polymorph
SK285547B6 (sk) 2002-11-08 2007-03-01 Zentiva, A. S. Spôsob prípravy Carvedilolu
WO2004094378A1 (en) 2003-04-21 2004-11-04 Matrix Laboratories Ltd Process for the preparation of carvedilol form-ii
WO2004113296A1 (en) 2003-06-20 2004-12-29 Sun Pharmaceutical Industries Limited A process for preparation of 1-[9h-carbazol-4-yloxy]- 3-[{2-(2-(-(methoxy)phenoxy)-ethyl}-amino]-propan-2-ol
SI21616A (sl) 2003-09-02 2005-04-30 Krka, Tovarna Zdravil, D.D., Novo Mesto Nove kristalne oblike karvedilola
US7750036B2 (en) 2003-11-25 2010-07-06 Sb Pharmco Puerto Rico Inc. Carvedilol salts, corresponding compositions, methods of delivery and/or treatment
EP1723107A2 (en) 2004-02-23 2006-11-22 Cadila Healthcare Ltd. Process for manufacture of racemic carvedilol
US20070191456A1 (en) 2004-04-22 2007-08-16 Tarur Venkatasubramanian R Novel process for the preparation of 1-(9h-carbazol-4-yloxy)-3-[[2-(-methoxyphenoxy)-ethyl] amino]-propan-2-ol
GB0411273D0 (en) 2004-05-20 2004-06-23 Cipla Ltd Process and product
PL1838670T3 (pl) 2004-12-09 2010-03-31 Zach System Spa Sposób wytwarzania karwedilolu i jego enancjomerów
US20070027202A1 (en) 2005-06-07 2007-02-01 Ashok Kumar Process for the preparation of carvedilol and its salts
ES2343141T3 (es) 2005-11-16 2010-07-23 F. Hoffmann-La Roche Ag Nuevo procedimiento para la preparacion de thoc.
WO2007077111A1 (en) 2005-12-30 2007-07-12 F. Hoffmann-La Roche Ag Compounds and methods for carbazole synthesis
KR100746455B1 (ko) 2006-02-23 2007-08-03 안국약품 주식회사 고광학순도의 키랄 카베딜롤의 제조방법

Also Published As

Publication number Publication date
IS7351A (is) 2004-07-13
KR20040077872A (ko) 2004-09-07
US6710184B2 (en) 2004-03-23
EP1474133A2 (en) 2004-11-10
CA2472377A1 (en) 2003-07-24
WO2003059807A3 (en) 2003-12-04
US20040171665A1 (en) 2004-09-02
US20090163721A1 (en) 2009-06-25
EP1474133A4 (en) 2006-02-01
AU2003205146A1 (en) 2003-07-30
MXPA04006909A (es) 2005-04-19
CN1298322C (zh) 2007-02-07
JP2005515226A (ja) 2005-05-26
CN1615133A (zh) 2005-05-11
US7598396B2 (en) 2009-10-06
US7514467B2 (en) 2009-04-07
PL371409A1 (en) 2005-06-13
HRP20040673A2 (en) 2005-06-30
ZA200405443B (en) 2005-07-08
US20030166702A1 (en) 2003-09-04
WO2003059807A2 (en) 2003-07-24

Similar Documents

Publication Publication Date Title
NO20043383L (no) Faste krystallinske stoffer av karvedilol og fremgangsmater for fremstilling av disse
AU2003213606A8 (en) Mp53s as modifiers of the p53 pathway and methods of use
PH12012501372A1 (en) Proteasome inhibitors and methods of using the same
IL189021A0 (en) Solid dosage forms of valsartan and amlodipine and method of making the same
ZA200608180B (en) Solid product dissolver and method of use thereof
AU2003303398A1 (en) Dowhole chemical sensor and method of using same
NO20051503D0 (no) Pyrazolopyridiner og fremgangsmater for fremstilling og anvendelse av de samme.
EP1682011A4 (en) ANASTOMOSIS APPARATUS AND METHODS OF DEPLOYMENT AND PRODUCTION
NO20055026D0 (no) Indolonacetamid-derivater, fremgangsmate for fremstilling og anvendelse av disse
EP1678157A4 (en) Heterocyclic compounds and process for their preparation and use
ZA200601293B (en) Proteasome inhibitors and methods of using the same
DK1589973T4 (da) Formulering og fremgangsmåder til behandling af thrombocytæmi
NO20054535D0 (no) Bifunksjonelle heterocykliske forbindelser og fremgangsmater for fremstilling og anvendelse av samme
AU2003297612A8 (en) 2-substituted-3-propenamide derivatives and methods of using the same
NO20043295L (no) Faste salt-benzazepinforbindelser og deres anvendelse ved fremstilling av farmasoytiske forbindelser
NO20052859D0 (no) Fremgangsmate for fremstilling av resperidon og intermediater derav
AU2003294684A8 (en) Ketoprofen compositions and methods of making them
AU2003284942A8 (en) Oral extended release tablets and methods of making and using the same
ZA200704791B (en) Tablets for the sustained release of indapamide and preparation method thereof
NO20026192D0 (no) Metode og innretning for å detektere opphopning av faste stoffer
AU2003295881A8 (en) Lamps as modifiers of the p53 pathway and methods of use
AU2003228597A8 (en) Antibodies for enzymes of the omega-oxidation pathway and methods relating thereto
AU2003303094A8 (en) Mat2as as modifiers of the p53 pathway and methods of use
NO20034422D0 (no) Löfteverktöy IIb og fremgangsmåte for anvendelse av samme
AU2003278811A8 (en) Ldlrs as modifiers of the p53 pathway and methods of use

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application